Moderna stock price rose to $96

Moderna stock price rose to $96.90 in after-hours trading, boosted by speculation of strategic partnerships. Market sentiment suggests possible collaborations could strengthen Moderna’s global distribution networks. The administration estimates this will save state programs "many millions of dollars," while setting the standard for other companies to follow. The main reason to buy Moderna is its use of mRNA technology to develop novel medicines. Messenger RNA is extremely complex, but it allows for the rapid development of lifesaving new drugs. The big proof point of this was the coronavirus vaccine that Moderna helped create during the pandemic. And that's just one example of what this healthcare company has done and can do. Moderna stock price climbed to $96.55 on optimism around its RSV vaccine trials. Analysts anticipate FDA submission timelines could be a key catalyst for investor sentiment moving forward.